Fowler John Franklin 4
4 · Kezar Life Sciences, Inc. · Filed Dec 15, 2021
Insider Transaction Report
Form 4
Fowler John Franklin
Director
Transactions
- Exercise/Conversion
Common Stock
2021-12-14$0.90/sh+7,700$6,930→ 366,904 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-12-14−7,700→ 82,721 totalExercise: $0.90Exp: 2025-09-09→ Common Stock (7,700 underlying)
Holdings
- 38,461(indirect: By LLC)
Common Stock
- 3,750(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person is a member of Montebello Holdings LLC. The reporting person disclaims Section 16 beneficial ownership of the securities held by Montebello Holdings LLC, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- [F2]Fully vested.